# A comprehensive economic assessment of the burden of obesity in Kuwait

**Authors:** Mouaddh Abdulmalik Nagi, Hanan Ahmed, Mohammad Almari, Ziyad S. Almalki, Yasir Mohammed Zaroug Elradi, Humaira Nisar, Sreeram V. Ramagopalan, Sreeram V. Ramagopalan, Sreeram V. Ramagopalan

PMC · DOI: 10.1371/journal.pone.0344040 · PLOS One · 2026-03-04

## TL;DR

This study estimates the massive economic costs of obesity in Kuwait in 2024, showing it exceeds the healthcare budget and GDP per capita.

## Contribution

The first comprehensive economic assessment of obesity's burden in Kuwait from both governmental and societal perspectives.

## Key findings

- The societal cost of obesity in Kuwait was KWD 4.3 billion in 2024, 1.3 times the healthcare budget.
- The mean annual societal cost per patient was KWD 1,737, or 17.6% of GDP per capita.
- Obesity caused 2 million morbidity and 961 mortality cases in Kuwait in 2024.

## Abstract

Obesity is a complex public health issue that has risen to epidemic proportions globally. The aim of this study was to estimate the economic costs associated with obesity from governmental and societal perspectives in the State of Kuwait in 2024.

A disease-specific prevalence-based cost-of-illness framework was applied. Key parameters include prevalence of obesity and its related comorbidities, relative risks, healthcare resources, income rate and growth, and lost workdays for patients and relatives, all were derived from literature. The outcomes measured were total healthcare costs, societal costs, and cost per patient, all reported in 2024 Kuwaiti Dinar (KWD), United States dollar ($), and Purchasing Power Parity (PPP).

In 2024, there were approximately 2 million morbidity cases and 961 mortality cases directly attributed to obesity in Kuwait. The economic burden of obesity was estimated at KWD 4.3 billion ($ 14 billion; PPP$ 21.6 billion) from societal perspective and KWD 3.9 billion ($12.8 billion, PPP 19.7 billion) from governmental perspective, almost 1.3 times healthcare budget. The mean annual societal cost per patient was KWD 1,737 ($5,676; PPP 8,729)—17.6% of 2024 Kuwaiti gross domestic product per capita. Furthermore, the mean direct medical cost per patient was KWD 1,586 ($5,184 or PPP 7,972); comprised 3 times the healthcare expenditure per capita.

Obesity and its comorbidities impose a far greater health and economic burden on Kuwait’s healthcare system and national productivity than previously recognized. This study calls for a paradigm shift toward early prevention, culturally tailored strategies, and comprehensive disease management. Expanding access to emerging innovative treatments and leveraging technology-driven tools are essential to support sustained weight management and reduce long-term impacts.

## Linked entities

- **Diseases:** obesity (MONDO:0011122)

## Full-text entities

- **Genes:** COX1 (cytochrome c oxidase subunit I) [NCBI Gene 4512] {aka COI, MTCO1}, GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}
- **Diseases:** depressive disorders (MESH:D003866), breast cancer (MESH:D001943), Musculoskeletal disorders (MESH:D009140), type II diabetes mellitus (MESH:D003924), KWD (MESH:C535850), associated (MESH:D018886), dementias (MESH:D003704), gastric cardia, liver, gallbladder, pancreas, prostate, kidney, thyroid, lymphoma (MESH:D004938), liver cancer (MESH:D006528), -illness (MESH:D002908), atrial fibrillation and flutter (MESH:D001282), productivity loss (MESH:D007787), back pain (MESH:D001416), leukemia (MESH:D007938), YPLL (MESH:D003643), thyroid cancer (MESH:D013964), hypertensive heart disease (MESH:D006973), meningioma (MESH:D008579), IHDs (MESH:D017202), gastrointestinal disorders (MESH:D005767), CVDs (MESH:D002318), CKD (MESH:D012080), neurological or mental health disorders (OMIM:603663), GBD (MESH:D001037), Obesity (MESH:D009765), gastric cancer (MESH:D013274), gallbladder and biliary cancers (MESH:D005706), noncommunicable diseases (MESH:D000073296), stroke (MESH:D020521), Overweight (MESH:D050177), esophagus adenocarcinoma (MESH:C562730), osteoarthritis (MESH:D010003), MBS (MESH:D008659), related diseases (MESH:D000077733), gallbladder disease (MESH:D005705), GERD (MESH:D005764), Burden of Disease (MESH:D004194), PCOS (MESH:D016649), OAF (MESH:D020969), gout (MESH:D006073), cancers (MESH:D009369), NAFL (MESH:D065626), multiple myeloma (MESH:D009101), mental and neurological disorders (MESH:D001523), alzheimer's disease (MESH:D000544), asthma (MESH:D001249), CKDs (MESH:D051436)
- **Chemicals:** PONE-D-25-47395R1 (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12959657/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12959657/full.md

## References

75 references — full list in the complete paper: https://tomesphere.com/paper/PMC12959657/full.md

---
Source: https://tomesphere.com/paper/PMC12959657